U.S. nonprofit hospitals have made some meaningful strides over the past few months – enough for Fitch Ratings to revise its outlook from deteriorating to neutral, the rating agency said this week.
Hollywood Firefighters Pension Fund, based in Florida, is suing UnitedHealth Group executives, including the late Brian Thompson, for alleged insider trading. The lawsuit, filed in May in federal court in Minnesota, also names UnitedHealth Group CEO Andrew Witty and board chairman Stephen Hemsley.
Sellers need to disclose any issues up-front, as clients lack 100% compliance on HIPAA regulations 100% of the time, says Adam Green, a partner in Davis Wright Tremaine.
The Congressional Budget Office has estimated that the expiration of enhanced subsidies for Affordable Care Act plans – which are set to expire in 2026 – could drive up premiums in the individual market.
The newly launched Illinois Resource Pool connects healthcare facilities with vetted, flexible local clinicians, says Robert Crowe, CEO and founder of Matchwell and EVP of per diem and local workforce strategies at Medical Solutions.
The Board of Governors of L.A. Health Plan has unanimously given the green light to appoint Martha Santana-Chin as its next CEO – making her the first female and Latina CEO to lead the organization, it said last week.
A group called Save Jennie Stuart has filed a lawsuit seeking to stop Deaconess Health’s planned acquisition of Jennie Stuart Medical Center in Hopkinsville, Kentucky.
If Congress doesn’t take action by the end of 2024 to make permanent waivers that have been extended for two years, the country goes back to March 2020 policy, says Tom Leary, senior vice president and head of government relations at HIMSS.
Authorities have charged Luigi Mangione, 26, with the second-degree murder of UnitedHealthcare CEO Brian Thompson. Police arrested Mangione in Altoona, Pennsylvania Monday morning after a McDonald’s employee recognized him from photos circulating of the suspected killer and called local police.
Precision medicine’s genomic solutions were a great first step, but they are limited compared to AI’s ability – for example, Artera’s test for localized prostate cancer and recommended therapy, says CEO Andre Esteva.